Takeda Named Global Top Employer for Seventh Consecutive Year
18 Januar 2024 - 1:00PM
Business Wire
- Achieved Global Recognition and Top Employer Certification
in 24 Countries from Top Employers Institute
- Global Recognition Reinforces Commitment to Creating an
Exceptional People Experience
Takeda (TSE:4502/NYSE:TAK) today announced
that for the seventh consecutive year, it has received global Top
Employer® certification for 2024. Takeda is one of just 17
companies that received global recognition, and it was additionally
certified as a Top Employer across 24 countries.
The Top Employers Institute program certifies organizations
based on the participation and results of their HR Best Practices
Survey. This survey covers 20 topics including people strategy,
work environment, talent acquisition, learning, diversity &
inclusion, well-being and more. Companies are evaluated on existing
policies and practices.
“Our colleagues work hard to help patients around the world,
which is why we focus on creating an exceptional people experience
at Takeda,” said Lauren Duprey, chief human resources officer,
Takeda. “Receiving this recognition from Top Employers Institute
confirms that prioritizing talent, well-being, learning and
diversity, equity and inclusion is the right approach – and that by
doing so, we’re enabling our people to discover and deliver
life-transforming treatments around the globe.”
“Exceptional times bring out the best in people and
organizations, and we have witnessed this in our Top Employers
Certification Program this year: an exceptional performance from
the certified Top Employers 2024. Amongst this community of
outstanding organizations, Takeda, has proven their commitment to
their employees on a global scale,” said David Plink, chief
executive officer, Top Employers Institute. “This consistency in
people practices across the globe characterizes an exclusive group
of companies that have achieved a global certification through the
Top Employers Program. We are proud to announce and celebrate these
companies and their achievement in 2024.”
Takeda excelled globally in the areas of ethics & integrity,
purpose & values, business strategy, employer branding and
organization & change. The full list of countries where Takeda
was named a Top Employer is below:
- Asia Pacific: Australia, China, India, Japan, South
Korea
- Europe: Austria, Czech Republic, France, Germany,
Ireland, Italy, Poland, Portugal, Slovakia, Spain, Switzerland,
United Kingdom
- Latin America: Argentina, Brazil, Colombia, Mexico
- Middle East: Israel
- North America: Canada and United States
To learn more about Top Employers Institute and the Top
Employers certification, please visit:
https://www.top-employers.com.
About Takeda
Takeda is focused on creating better health for people and a
brighter future for the world. We aim to discover and deliver
life-transforming treatments in our core therapeutic and business
areas, including gastrointestinal and inflammation, rare diseases,
plasma-derived therapies, oncology, neuroscience and vaccines.
Together with our partners, we aim to improve the patient
experience and advance a new frontier of treatment options through
our dynamic and diverse pipeline. As a leading values-based,
R&D-driven biopharmaceutical company headquartered in Japan, we
are guided by our commitment to patients, our people and the
planet. Our employees in approximately 80 countries and regions are
driven by our purpose and are grounded in the values that have
defined us for more than two centuries. For more information, visit
www.takeda.com.
Important Notice
For the purposes of this notice, “press release” means this
document, any oral presentation, any question and answer session
and any written or oral material discussed or distributed by Takeda
Pharmaceutical Company Limited (“Takeda”) regarding this release.
This press release (including any oral briefing and any
question-and-answer in connection with it) is not intended to, and
does not constitute, represent or form part of any offer,
invitation or solicitation of any offer to purchase, otherwise
acquire, subscribe for, exchange, sell or otherwise dispose of, any
securities or the solicitation of any vote or approval in any
jurisdiction. No shares or other securities are being offered to
the public by means of this press release. No offering of
securities shall be made in the United States except pursuant to
registration under the U.S. Securities Act of 1933, as amended, or
an exemption therefrom. This press release is being given (together
with any further information which may be provided to the
recipient) on the condition that it is for use by the recipient for
information purposes only (and not for the evaluation of any
investment, acquisition, disposal or any other transaction). Any
failure to comply with these restrictions may constitute a
violation of applicable securities laws.
The companies in which Takeda directly and indirectly owns
investments are separate entities. In this press release, “Takeda”
is sometimes used for convenience where references are made to
Takeda and its subsidiaries in general. Likewise, the words “we,”
“us” and “our” are also used to refer to subsidiaries in general or
to those who work for them. These expressions are also used where
no useful purpose is served by identifying the particular company
or companies.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240118372418/en/
Media: Japanese Media Jun Saito
jun.saito@takeda.com
U.S. and International Media Megan Ostrower
megan.ostrower@takeda.com
Takeda Pharmaceutical (NYSE:TAK)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Takeda Pharmaceutical (NYSE:TAK)
Historical Stock Chart
Von Mai 2023 bis Mai 2024